BamSEC and AlphaSense Join Forces
Learn More

Adnexus Therapeutics, Inc.

Material Contracts Filter

EX-10.28
from S-1 9 pages Severance and Change of Control Agreement
12/34/56
EX-10.27
from S-1 9 pages Severance and Change of Control Agreement
12/34/56
EX-10.26
from S-1 9 pages Severance and Change of Control Agreement
12/34/56
EX-10.25
from S-1 9 pages Severance and Change of Control Agreement
12/34/56
EX-10.24
from S-1 9 pages Severance and Change of Control Agreement
12/34/56
EX-10.23
from S-1 6 pages April 24, 2005 Dr. John Mendlein 99 Harbour Square #2708 Toronto, Canada M5j 2h2 April 24, 2005 Dear John,
12/34/56
EX-10.22
from S-1 42 pages Adnexus Therapeutics, Inc. Second Amended and Restated Investor Rights Agreement
12/34/56
EX-10.16
from S-1 9 pages Adnexus Therapeutics, Inc. Nonstatutory Stock Option Agreement Granted Under 2002 Stock Incentive Plan
12/34/56
EX-10.15
from S-1 10 pages Adnexus Therapeutics, Inc. Incentive Stock Option Agreement Granted Under 2002 Stock Incentive Plan
12/34/56
EX-10.14
from S-1 15 pages Adnexus Therapeutics, Inc. Restricted Stock Agreement Granted Under 2002 Stock Incentive Plan
12/34/56
EX-10.13
from S-1 11 pages Compound Therapeutics, Inc. 2002 Stock Incentive Plan
12/34/56
EX-10.12
from S-1 11 pages This Warrant and the Shares Issuable Hereunder Have Not Been Registered Under the Securities Act of 1933, as Amended, and May Not Be Sold, Pledged or Otherwise Transferred Without an Effective Registration Thereof Under Such Act or Pursuant to Rule 144 or an Opinnion of Counsel Reasonably Satisfactory to the Company and Its Counsel That Such Registration Is Not Required. Warrant to Purchase Stock Corporation: Compound Therapeutics, Inc. Number of Shares: 2.5% Coverage of Term Advances Class of Stock: Series a Preferred Initial Exercise Price: $0.50 Per Share Issue Date: July 8, 2005 Expiration Date: July , 2012
12/34/56
EX-10.11
from S-1 9 pages This Warrant and the Shares Issuable Hereunder Have Not Been Registered Under the Securities Act of 1933, as Amended, and May Not Be Sold, Pledged or Otherwise Transferred Without an Effective Registration Thereof Under Such Act or Pursuant to Rule 144 or an Opinion of Counsel Reasonably Satisfactory to the Company and Its Counsel That Such Registration Is Not Required. Warrant to Purchase Stock Corporation: Compound Therapeutics, Inc. Number of Shares: 5% Coverage of Term Advances Class of Stock: Series a Preferred Initial Exercise Price: $0.75 Per Share Issue Date: December 15, 2003 Expiration Date: December 15, 2010
12/34/56
EX-10.9
from S-1 12 pages Warrant to Purchase Up to 54,000 Shares of Common Stock
12/34/56
EX-10.8
from S-1 46 pages Master Security Agreement Dated as of February ___, 2002
12/34/56
EX-10.7
from S-1 70 pages Lease Agreement
12/34/56
EX-10.6
from S-1 12 pages License Agreement
12/34/56
EX-10.5
from S-1 22 pages Mutual Patent License Agreement
12/34/56
EX-10.4
from S-1 90 pages License, Manufacturing and Supply Agreement
12/34/56
EX-10.3
from S-1 15 pages License Agreement 1. Definitions
12/34/56